fbpx Skip to content
LIFT-AD-Web-Trial-Logo_RGB-copy
  • About LIFT-AD
  • Open Label Extension
  • Study Locations
  • What to Expect
  • Resources
  • News
  • Contact

In the News

By clicking on the links below, you will leave Athira's website. Athira does not endorse or update statements on such third party websites

Clinical trial to begin for new Alzheimer’s disease treatment

May 17, 2021

Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family.

April 21, 2021

An interview with Dr. Charles Bernick, MD, MPH, a clinical professor at the University of Washington Department of Neurology who has researched Alzheimer’s Disease and treatments for 25 years.

April 21, 2021

Wanted: Mild to Moderate Alzheimer’s Patients for Clinical Trials!

March 16, 2021
  • « Previous
  • 1
  • 2

About LIFT-AD
Open Label Extension (ATH-1017 Study 203)
Study Locations
What to Expect
Resources
Contact

Trial sponsored by  
clinicaltrials@athira.com

 

©2022 Athira Pharma | Privacy Policy

Scroll To Top